Brief: iSpecimen Inc Selected by U.S. Government and Private Researchers to Supply Critical Human Biospecimens for Advanced Phase of COVID-19 Research
Nov 22 (Reuters) - iSpecimen Inc ISPC.O :
* ISPECIMEN INC - SELECTED BY U.S. GOVERNMENT AND PRIVATE
RESEARCHERS TO SUPPLY CRITICAL HUMAN BIOSPECIMENS FOR ADVANCED
PHASE OF COVID-19 RESEARCH
* ISPECIMEN INC - MULTIPLE PROJECTS WITH MYRIAD OBJECTIVES
ARE
UNDER WAY
Source text for Eikon: ID:nPn26wms7a
Further company coverage: ISPC.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on iSpecimen
See all newsBrief: iSpecimen Enters Asset Purchase Agreement With FoldLab AI On September 4
Brief: iSpecimen Appoints Shahin Behrozyan CEO, Katharyn Field To Leave Role
Brief: Ispecimen - Enters Settlement Agreement With Westpark Capital On August 6, 2026
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM